Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -15.46%20.1M | -10.57%114.8M | -35.23%19.75M | 1.00%41.06M | -6.40%30.22M | -4.65%23.78M | -12.55%128.36M | -18.39%30.49M | 6.19%40.65M | -16.03%32.28M |
| Cost of revenue | -12.68%14.57M | -11.56%78.01M | -38.55%13M | -3.76%27.14M | -4.60%21.19M | 0.25%16.68M | -11.96%88.21M | -17.24%21.16M | 8.86%28.2M | -15.73%22.21M |
| Gross profit | -21.99%5.54M | -8.38%36.79M | -27.71%6.75M | 11.76%13.92M | -10.37%9.02M | -14.48%7.1M | -13.82%40.15M | -20.89%9.33M | 0.61%12.45M | -16.67%10.07M |
| Operating expense | -2.43%9.8M | 35.24%53.06M | 3.07%10.92M | 14.21%11.72M | 3.60%10.53M | -5.26%10.04M | -36.24%39.24M | -20.66%10.6M | -60.75%10.26M | 57.30%10.16M |
| Selling and administrative expenses | ---- | -0.84%35.77M | ---- | ---- | ---- | ---- | -9.90%36.07M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 1.84%22.62M | ---- | ---- | ---- | ---- | 4.14%22.21M | ---- | ---- | ---- |
| -General and administrative expense | ---- | -5.13%13.15M | ---- | ---- | ---- | ---- | -25.90%13.86M | ---- | ---- | ---- |
| Other operating expenses | -2.45%9.8M | 182.85%17.74M | 0.40%10.95M | 10.67%11.73M | 3.59%10.53M | -5.29%10.05M | -71.28%6.27M | 134.27%10.9M | -59.63%10.6M | -13.72%10.17M |
| Total other operating income | -28.57%5K | -85.67%445.2K | -91.53%26K | -99.40%2K | -12.50%7K | -30.00%7K | 843.65%3.11M | 105.97%307K | 244.79%331K | -99.85%8K |
| Operating profit | -44.75%-4.26M | -1,879.44%-16.28M | -229.68%-4.18M | 0.23%2.19M | -1,532.61%-1.5M | -28.01%-2.94M | 106.12%914.78K | 18.93%-1.27M | 115.90%2.19M | -101.64%-92K |
| Net non-operating interest income (expenses) | -83.33%-88K | -22.90%-271.38K | -132.43%-86K | -6.67%-80K | -16.67%-49K | 28.36%-48K | 19.30%-220.81K | 64.97%-37K | 27.18%-75K | 4.55%-42K |
| Non-operating interest expense | 83.33%88K | 29.97%269.47K | 132.43%86K | 6.67%80K | 16.67%49K | -28.36%48K | 4.73%207.33K | 23.47%37K | -27.18%75K | -4.55%42K |
| Total other finance cost | ---- | -85.78%1.92K | ---- | ---- | ---- | ---- | -82.18%13.48K | ---- | ---- | ---- |
| Net investment income | 36.84%104K | 100.00%382K | 80.95%152K | 300.00%72K | 95.24%82K | 61.70%76K | 191K | 84K | -5.26%18K | -4.55%42K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 108.40%581K | -498.96%-10.02M | 31.58%-2.27M | -99.09%37K | -918.60%-876K | -478.17%-6.91M | 2.51M | -3.31M | 4.08M | -86K |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -29.71%223.96K | 116.29%318.64K | ||||||||
| Less:Write off | ---- | 29.71%-223.96K | ---- | ---- | ---- | ---- | -116.29%-318.64K | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 62.73%-3.66M | -1,712.21%-16.33M | -40.71%-6.38M | -64.22%2.22M | -1,217.42%-2.35M | -1,901.63%-9.83M | 105.89%1.01M | -21.03%-4.53M | 144.85%6.21M | -103.17%-178K |
| Income tax | 0 | 145.41%384.45K | 119.79%384K | 0 | 0 | 0 | -173.20%-846.59K | -510.48%-1.94M | 66.34%682K | 156.30%346K |
| Net income | 62.73%-3.66M | -998.77%-16.71M | -160.84%-6.76M | -59.81%2.22M | -347.52%-2.35M | -1,667.63%-9.83M | 110.14%1.86M | 38.53%-2.59M | 138.78%5.53M | -109.55%-524K |
| Net income continuous operations | 62.73%-3.66M | -998.77%-16.71M | -160.84%-6.76M | -59.81%2.22M | -347.52%-2.35M | -1,667.63%-9.83M | 110.14%1.86M | 38.53%-2.59M | 138.78%5.53M | -109.55%-524K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 62.73%-3.66M | -998.77%-16.71M | -160.84%-6.76M | -59.81%2.22M | -347.52%-2.35M | -1,667.63%-9.83M | 110.14%1.86M | 38.53%-2.59M | 138.78%5.53M | -109.55%-524K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 62.73%-3.66M | -998.77%-16.71M | -160.84%-6.76M | -59.81%2.22M | -347.52%-2.35M | -1,667.63%-9.83M | 110.14%1.86M | 38.53%-2.59M | 138.78%5.53M | -109.55%-524K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 62.87%-0.0075 | -1,005.26%-0.0344 | -162.26%-0.0139 | -59.65%0.0046 | -336.36%-0.0048 | -1,736.36%-0.0202 | 110.08%0.0038 | 39.08%-0.0053 | 138.91%0.0114 | -109.73%-0.0011 |
| Diluted earnings per share | 62.87%-0.0075 | -1,005.26%-0.0344 | -162.26%-0.0139 | -59.65%0.0046 | -336.36%-0.0048 | -1,736.36%-0.0202 | 110.08%0.0038 | 39.08%-0.0053 | 138.91%0.0114 | -109.73%-0.0011 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.